The Novogy management team brings a valuable range of cross disciplinary experience to the challenge of creating executable technology in the bio-processing arena. The team is aligned around the challenge of creating a broad operational platform of next generation biomolecules. By understanding that solutions in this space go beyond lab-based engineering of products, the team is focused on delivering processing solutions that encompass molecular biology, microbiology and process innovation.
Dr. Greg Stephanopoulos
Dr. Stephanopoulos is the W.H. Dow Professor of Chemical Engineering and Biotechnology at MIT, the Taplin Professor of Harvard/MIT Health Sciences and Technology Division, and Instructor of Bioengineering at Harvard Medical School.
He has co-authored or co-edited five books, more than 360 papers and 50 patents, and supervised more than 110 graduate and post-doctoral students. He is editor-in-chief of Metabolic Engineering and Current Opinion in Biotechnology, and serves on the Editorial Boards of seven scientific journals and the Advisory Boards of five ChE departments. He is a member of the American Institute of Chemical Engineers (AIChE) Board of Directors, the National Academy of Engineering (NAE) and holds an honorary doctorate degree from the Technical University of Denmark.
Dr. Stephanopoulos directs a research group of approximately 25 researchers, who work on applications of metabolic engineering for the production of fuels and chemicals, and he teaches undergraduate and graduate courses in Chemical Engineering and Biotechnology.
He received a BS in Chemical Engineering from National Technical University, Athens, Greece, a MS in Chemical Engineering from the University of Florida, and a PhD in Chemical Engineering from the University of Minnesota.
- Back to Top
Ginja R. Tavares da Silva
Ms. Silva has more than 15 years of experience in investment banking and has placed over $1.3 billion in renewable fuels financing. She led the IPO and listing on the NYSE for VeraSun, the first sole corn ethanol company.
Previously, she has held positions as Senior Vice President of Finance at Mascoma Coproration; Vice President of Finance, Treasurer and Corporate Secretarty of VeraSun Energy, Vice President and Associate with Conifer Investments, LLC; and as an Analyst with U.S. Bancorp and Standard Insurance Company.
Ms. Silva has worked on corporate restructurings, securing corporate credit ratings, managing relationships with investors, lenders and financial advisors. As an investment banker she focused on corporate finance and merger and acquisition transactions for the energy and financial services sectors, and venture investing for high tech start-up companies.
Ms. Silva received a AB degree in Economics and Mathematics from Smith College.
- Back to Top
Dr. A. Joe Shaw
Senior Director, Research & Development
Dr. Shaw leads Novogy's Research and Development team. Dr. Shaw has grown the R&D team and successfully develops and leads the function's direction.
Previously, Dr. Shaw led advanced products and metabolic engineering teams over the course of his five years at Mascoma Corporation. He played an instrumental role in project conception, execution and intellectual property development.
He has co-authored over ten papers and eight patent applications, and he has experience with strain engineering projects in E. coli, S. cerevisiae, non-conventional yeasts and thermophilic bacteria.
Dr. Shaw received a BA degree in Engineering from Dartmouth College, a BE in Chemical Engineering and a PhD in Biochemical Engineering from the Thayer School of Engineering at Dartmouth College.
- Back to Top